We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.72T
$967M 4.63%
4,150,902
+57,060
+1% +$12.7M
MSFT icon
2
Microsoft
MSFT
$2.83T
$772M 3.69%
1,794,763
-18,350
-1% -$7.84M
VOO icon
3
Vanguard S&P 500 ETF
VOO
$967B
$734M 3.51%
1,390,286
+44,627
+3% +$22.7M
IJR icon
4
iShares Core S&P Small-Cap ETF
IJR
$109B
$693M 3.31%
5,921,479
+307,333
+5% +$34.7M
SPY icon
5
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$500M 2.39%
871,999
-1,524
-0.2% -$843K
LLY icon
6
Eli Lilly
LLY
$1.06T
$316M 1.51%
356,296
-5,297
-1% -$4.76M
JPM icon
7
JPMorgan Chase
JPM
$930B
$272M 1.3%
1,289,233
+3,474
+0.3% +$732K
JNJ icon
8
Johnson & Johnson
JNJ
$624B
$269M 1.29%
1,662,889
+49,891
+3% +$7.95M
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$3.89T
$268M 1.28%
1,616,190
-8,622
-0.5% -$1.45M
AMZN icon
10
Amazon
AMZN
$2.51T
$265M 1.27%
1,422,753
-49,346
-3% -$9M
ORCL icon
11
Oracle
ORCL
$346B
$261M 1.25%
1,532,672
+83,477
+6% +$12.1M
HD icon
12
Home Depot
HD
$324B
$245M 1.17%
604,377
+50,278
+9% +$18.3M
GOOG icon
13
Alphabet (Google) Class C
GOOG
$3.89T
$245M 1.17%
1,463,919
-60,003
-4% -$10.2M
VB icon
14
Vanguard Small-Cap ETF
VB
$79.3B
$224M 1.07%
945,594
-2,051
-0.2% -$466K
PG icon
15
Procter & Gamble
PG
$342B
$205M 0.98%
1,181,534
-19,954
-2% -$3.39M
MA icon
16
Mastercard
MA
$469B
$197M 0.94%
397,977
-1,901
-0.5% -$884K
ACN icon
17
Accenture
ACN
$84.9B
$188M 0.9%
530,766
-7,636
-1% -$2.51M
XOM icon
18
ExxonMobil
XOM
$650B
$184M 0.88%
1,573,789
+27,900
+2% +$3.22M
ABT icon
19
Abbott
ABT
$175B
$173M 0.83%
1,516,845
-19,297
-1% -$2.12M
META icon
20
Meta Platforms (Facebook)
META
$1.54T
$173M 0.83%
301,794
-1,043
-0.3% -$537K
PEP icon
21
PepsiCo
PEP
$184B
$169M 0.81%
996,173
-13,459
-1% -$2.31M
CVX icon
22
Chevron
CVX
$387B
$163M 0.78%
1,104,986
-16,520
-1% -$2.46M
NVDA icon
23
NVIDIA
NVDA
$5.06T
$161M 0.77%
1,325,358
+94,091
+8% +$11.1M
VTI icon
24
Vanguard Total Stock Market ETF
VTI
$654B
$158M 0.75%
556,652
-3,228
-0.6% -$880K
RTX icon
25
RTX Corp
RTX
$282B
$155M 0.74%
1,278,973
-580
-0% -$66.1K
1
2 3 4 5

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.